A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round. . . . → Read More: Antibody Drug Biotech Raises $105M in Venture Funds
|
|||||
|
       
  |
Two companies are using deep learning and virtual reality to design treatments for Covid-19 infections, attacking a different target than most drugs being developed. . . . → Read More: Covid-19 Therapies Designed with Virtual Reality, A.I. 
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic. . . . → Read More: FDA Analyzing Real-World Evidence on Covid-19 
Companies that offer biotechnology, diagnostics, and analytics are testing liquid biopsies to make personalized diagnosis and care feasible for lung cancer patients. . . . → Read More: Trial Tests Liquid Biopsy Feasibility in Lung Cancer 
The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals. . . . → Read More: FDA Stops Home Covid-19 Diagnostic Test 
A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic. . . . → Read More: Mayo Clinic, A.I. Company Study Covid-19 Heart Disease  Comments are closed  Joint ventures/collaborations  biomedical, clinical trials, Covid-19, engineering, entrepreneurs, heart disease, life sciences, mathematics, medical device, physical sciences 
Data from millions of smartphone app users in the U.K. and U.S. reporting on Covid-19 symptoms show they could estimate a population’s Covid-19 infections. . . . → Read More: Symptom App, Algorithm Predict Covid-19 Infections 3 comments - (Comments are closed) New products biomedical, Covid-19, engineering, life sciences, mathematics, medical device, physical sciences, software, U.K., university 
A university spin-off company designing synthetic viruses with artificial intelligence to deliver gene therapies is licensing its work for eye and muscle disorders. . . . → Read More: Pharmas License A.I.-Aided Gene Therapies Comments are closed Intellectual property biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, university 
A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Microsoft, Biotech Examine Covid-19 Immune Response One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, Covid-19, genomics, life sciences, mathematics, medical device, physical sciences 
Clinical trial results show a technique visualizing cells in the retina and analyzed with an algorithm accurately predicts the progression of glaucoma. . . . → Read More: A.I.-Aided Method Predicts Glaucoma Progression Comments are closed New products biomedical, clinical trials, engineering, entrepreneurs, licensing, life sciences, mathematics, medical device, patent, pharmaceuticals, U.K., university |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||